COMMUNIQUÉS West-GlobeNewswire

Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company
30/04/2026
Proven immunology-focused executive and physician-scientist who has led companies from inception to IPO, driven multiple regulatory approvals, and helped build multi-billion-dollar therapeutic portfolios BOSTON, April [...]
Elutia to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
30/04/2026
GAITHERSBURG, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its first quarter 2026 [...]
FibroBiologics Reports Q1 2026 Financial Results and Provides Corporate Update
30/04/2026
On track for first patient dosed in phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers in Q2 of 2026 HOUSTON, April 30, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a [...]
PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June
30/04/2026
SAN JOSE, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, [...]
Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody
30/04/2026
Novel dual-mechanism anti-IgE antibody designed to improve upon existing and emerging therapies for IgE-mediated diseases Cue Biopharma plans to initiate global Phase 2b trial in food allergy following anticipated [...]
Alvotech Announces a Change in its Executive Team
30/04/2026
REYKJAVIK, ICELAND (April 30, 2026) — Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that [...]
Nyxoah to Participate in the Bank of America 2026 Healthcare Conference
30/04/2026
Nyxoah to Participate in the Bank of America 2026 Healthcare Conference Mont-Saint-Guibert, Belgium – April 30, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a [...]
Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026
30/04/2026
SOUTH SAN FRANCISCO, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for [...]
Larimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich’s Ataxia
30/04/2026
BALA CYNWYD, Pa., April 30, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today [...]
DBV Technologies publie ses résultats financiers du 1er trimestre 2026
30/04/2026
Châtillon, France, 30 avril 2026 DBV Technologies publie ses résultats financiers du 1er trimestre 2026 Trésorerie et équivalents de trésorerie de 229 millions de dollars au 31 mars 2026, portant l’horizon de trésorerie [...]
CooperCompanies Announces Release Date for Second Quarter 2026
30/04/2026
SAN RAMON, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report second quarter 2026 financial results on Thursday, June 4, [...]
Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection
30/04/2026
Ongoing Phase 1b human challenge study with oral, direct-acting protease inhibitor is designed to demonstrate proof-of-concept as a preventive and a treatment Fully enrolled first cohort is assessing the infectivity of [...]
CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026
30/04/2026
SARATOGA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced [...]
Emergent BioSolutions Reports First Quarter 2026 Financial Results
30/04/2026
First Quarter 2026 Total Revenues of $156.1 million First Quarter 2026 Net Income of $6.8 million and Net Income Margin of 4% First Quarter 2026 Adjusted EBITDA of $35.6 million and Adjusted EBITDA Margin of 23% [...]
Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference
30/04/2026
Primary and subgroup analysis from the Phase 2b CORAL trial of nalbuphine ER for the treatment of patients with IPF-related chronic cough accepted for oral presentation, including key subgroup analyses by baseline cough [...]
Leo International Precision Health AG Reports 2025 Results and Establishes Strategic Foundation for AI-Driven Precision Health Platform
30/04/2026
Planegg/Martinsried, Germany, April 30, 2026 – Leo International Precision Health AG (“LIPH” or the “Company”, ticker symbol: LEOW), a holding company building a global integrated AI-driven healthcare ecosystem, today [...]
BioStem Technologies to Host First Quarter 2026 Financial Results Conference Call on May 14, 2026
30/04/2026
Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, [...]
Stryker reports first quarter 2026 operating results
30/04/2026
Portage, Michigan, April 30, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2026: First Quarter Results Reported net sales increased 2.6% to $6.0 billion Organic net [...]
The Ensign Group Acquires Real Estate and Expands Operations in Texas
30/04/2026
SAN JUAN CAPISTRANO, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign TM group of companies, which invest in and provide skilled nursing and senior [...]

Pages